A panel of lawmakers in Vermont has advanced a measure that would establish a working group to study whether and how to allow therapeutic access to psychedelics in the state. If the bill is enacted, a report from the working group would be due to the legislature in November with recommendations on how to regulate the substances.
The Senate Appropriations committee approved S. 114 on a 6–0 vote last week. The panel did not adopt any amendments, though members at one point floated the idea of reducing the working group’s number of planned meetings from eight down to five.
The bill is now pending a second reading vote on the Senate floor, which come come as soon as Tuesday.
Under the proposal in its current form, Vermont would establish an eight-member Psychedelic Therapy Advisory Working Group that would “examine the use of psychedelics to improve physical and mental health and to make findings and recommendations regarding the advisability of the establishment of a State program similar to other jurisdictions to permit health care providers to administer psychedelics in a therapeutic setting and the impact on public health of allowing individuals to legally access psychedelics under state law.”
As originally introduced
Read full article on Marijuana Moment
